- Condition: Uterine Prolapse
Interventions: Procedure: Laparoscopic supracervical hysterectomy with sacropexy; Procedure: Vaginal hysterectomy with uterosacral colposuspension
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Not yet recruiting - verified May 2012 - Conditions: Cervical Cancer; Oropharyngeal Cancer; Vaginal Cancer; Anal Cancer; Penile Cancer
Interventions: Drug: Fluderabine; Drug: Cycolphosphamide; Biological: Young TIL; Biological: Aldesleukin
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Cervical Cancer; Endometrial Cancer; Esophageal Cancer; Fallopian Tube Cancer; Gastric Cancer; Ovarian Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
Intervention:
Sponsors: Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Surrey
Recruiting - verified April 2012 - Condition: Venous Thromboembolic Diseases
Interventions: Drug: Bemiparin; Drug: Enoxaparin; Other: control group
Sponsors: Hawler Medical University; Hawler Medical University
Recruiting - verified May 2012 - Condition: Levator Ani Syndrome
Interventions: Drug: Nifedipine; Drug: Placebo Ointment Base
Sponsors: Vanderbilt University; Vanderbilt University
Not yet recruiting - verified April 2012 - Condition: Adverse Effect of Oral Contraceptives, Sequela
Intervention: Drug: oc:E-E-desogestrel/vaginal ring:E-E -ethonogestrel
Sponsors: University of Oulu; University of Oulu
Recruiting - verified May 2012 - Conditions: Vaginal Inflammation; Vaginal Infections
Interventions: Drug: Imiquimod; Drug: HEC Placebo; Drug: Nonoxynol-9
Sponsors: CONRAD; CONRAD
Recruiting - verified May 2012 - Condition: Bacterial Vaginosis
Interventions: Drug: Lactobacillus acidophilus; Drug: Placebo
Sponsors: Università degli Studi di Brescia; Università degli Studi di Brescia; Azienda Ospedaliera Spedali Civili di Brescia
Recruiting - verified March 2012 - Condition: Recto-vaginal Fistula
Intervention: Drug: Adipose-derived stem cells without expanded
Sponsors: Instituto de Investigación Hospital Universitario La Paz; Instituto de Investigación Hospital Universitario La Paz
Recruiting - verified March 2012 - Condition: HIV Infections
Interventions: Drug: Dapivirine; Other: Placebo
Sponsors: International Partnership for Microbicides, Inc.; International Partnership for Microbicides, Inc.
Not yet recruiting - verified February 2012 - Conditions: Myoma; Adenomyosis
Intervention: Device: comparison multiple channel port laparoscopic surgery
Sponsors: Taipei Veterans General Hospital,Taiwan; Taipei Veterans General Hospital,Taiwan
Recruiting - verified March 2012 - Conditions: Child Abuse; Vaginismus; Dystocia; Depression
Intervention:
Sponsors: Hillel Yaffe Medical Center; Hillel Yaffe Medical Center; The Baruch Padeh Medical Center, Poriya
Not yet recruiting - verified January 2012 - Condition: Refractory Overactive Bladder
Intervention:
Sponsors: University of Oklahoma; University of Oklahoma
Recruiting - verified January 2012 - Condition: Chronic Postsurgical Pain
Intervention: Procedure: vaginal or laparoscopic hysterectomy
Sponsors: Tampere University Hospital; Tampere University Hospital
Recruiting - verified February 2012 - Condition: Pelvic Organ Prolapse
Intervention: Procedure: Preventive transobturator tension free vaginal tape
Sponsors: HaEmek Medical Center, Israel; HaEmek Medical Center, Israel
Not yet recruiting - verified January 2012 - Condition: Pelvic Organ Prolapse
Interventions: Procedure: Elevate Mesh; Procedure: Anterior Colporrhaphy
Sponsors: Mayo Clinic; Emanuel Trabuco; American Medical Systems
Recruiting - verified May 2012 - Condition: Vulvovaginal Candidiasis
Intervention: Drug: MGCD290
Sponsors: MethylGene Inc.; MethylGene Inc.
Recruiting - verified April 2012 - Conditions: Vulvodynia; Dyspareunia; Breast Cancer; Menopause
Intervention: Drug: Topical liquid lidocaine
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Drug: 1% tenofovir gel; Drug: Placebo gel
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2012 - Condition: Bacterial Vaginosis
Intervention: Drug: Trimo-San gel
Sponsors: Medstar Research Institute; Medstar Research Institute; University of New Mexico
Recruiting - verified November 2011 - Conditions: Pelvic Organ Prolapse; Gynecologic Cancers; Uterine Leiomyomata; Adenomyosis; Endometrial Hyperplasia; Other Abnormal Uterine and Vaginal Bleeding; Pelvic Mass; Pelvic Pain
Intervention:
Sponsors: University of South Florida; University of South Florida
Recruiting - verified October 2011 - Condition: Sexual Dysfunction, Physiological
Interventions: Device: Vaginal Renewal Program; Device: Vaginal Dilator
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified September 2011 - Condition: Bacterial Vaginosis
Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol); Dietary Supplement: Placebo
Sponsors: Ohio State University; Ohio State University
Recruiting - verified October 2011 - Condition: Recurrent Bacterial Vaginosis (BV)
Interventions: Drug: 1% SPL7013 Gel; Drug: 3% SPL7013 Gel; Drug: placebo gel
Sponsors: Starpharma Pty Ltd; Starpharma Pty Ltd
Recruiting - verified April 2012 - Conditions: Threatened Abortion; Pre-Eclampsia; Abruptio Placentae; Fetal Growth Retardation; Premature Birth
Interventions: Drug: dihydroxyprogesterone caproate; Drug: Placebo
Sponsors: Soroka University Medical Center; Soroka University Medical Center
Not yet recruiting - verified December 2011 - Condition: Vaginal Fistula
Interventions: Procedure: 7-day catheterization following fistula repair surgery; Procedure: 14 day catheterization
Sponsors: EngenderHealth; EngenderHealth; World Health Organization; United States Agency for International Development (USAID)
Not yet recruiting - verified September 2011 - Condition: Breast Cancer
Interventions: Other: questionnaire administration; Drug: fluocinonide cream; Procedure: management of therapy complications
Sponsors: OHSU Knight Cancer Institute; OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Vaginitis
Interventions: Drug: Palmitoylethanolamide vaginal cream; Drug: Placebo vaginal cream
Sponsors: Università degli Studi dell'Insubria; Università degli Studi dell'Insubria
Not yet recruiting - verified July 2011 - Condition: Vaginal Prolapse
Intervention:
Sponsors: University of South Florida; University of South Florida
Recruiting - verified August 2011 - Condition: Value of the Bowel Preparation Versus Diet Change
Interventions: Other: No bowel prep; Other: Clear liquid diet and 2 Fleet's enemas
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified April 2012 - Condition: Bacterial Vaginosis
Interventions: Drug: Vaginal capsules of lactobacilli; Drug: Vaginal capsules of lactobacilli
Sponsors: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine; The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine; Ministry of Health, China
Recruiting - verified August 2011 - Condition: Obesity
Intervention: Procedure: Transvaginal NOTES sleeve gastrectomy
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified July 2011 - Conditions: Cervical Cancer; Uterine Cancer; Vaginal Cancer; Carcinoma of the Vulva
Intervention: Procedure: Image-guided brachytherapy
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute
Recruiting - verified February 2012 - Condition: Vaginosis, Bacterial
Intervention: Drug: Etonogestrel /Ethinyl Estradiol Contraceptive Vaginal Ring
Sponsors: Eastern Virginia Medical School; Eastern Virginia Medical School; Merck
Recruiting - verified April 2012 - Condition: Vaginal Vault Prolapse
Intervention: Other: Examination
Sponsors: Kantonsspital Aarau; Kantonsspital Aarau
Recruiting - verified July 2011 - Condition: Urinary Stress Incontinence
Intervention:
Sponsors: Western Galilee Hospital-Nahariya; Western Galilee Hospital-Nahariya
Recruiting - verified July 2011 - Condition: HIV Prevention
Interventions: Drug: Tenofovir gel; Drug: Universal placebo gel
Sponsors: CONRAD; CONRAD; Follow-on African Consortium for Tenofovir Studies (FACTS); United States Agency for International Development (USAID)
Recruiting - verified May 2012 - Conditions: Postpartum Bleeding; Vaginal Lacerations; Cervical Lacerations
Interventions: Device: The HemCon GuardaCare; Device: Control
Sponsors: Soroka University Medical Center; Soroka University Medical Center; HemCon Medical Technologies, Inc
Recruiting - verified April 2011 - Condition: Cancer
Interventions: Drug: prasterone; Other: placebo
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Pelvic Organ Prolapse
Intervention: Device: Restorelle Direct Fix A&P
Sponsors: Coloplast A/S; Coloplast A/S
Recruiting - verified March 2012 - Condition: Pelvic Organ Prolapse
Intervention:
Sponsors: The Cleveland Clinic; The Cleveland Clinic; The Christ Hospital; Washington Hospital Center; Providence Healthcare in British Columbia; Stanford University; Women and Infants Hospital of Rhode Island; Greater Baltimore Medical Center; University of North Carolina
Recruiting - verified September 2011 - Condition: Prolapse of Vaginal Vault After Hysterectomy
Intervention: Procedure: uterosacral ligament suspension colpopexy bilateral
Sponsors: Kaiser Permanente; Kaiser Permanente
Recruiting - verified February 2012 - Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Ring; Drug: Maraviroc Vaginal Ring; Other: Placebo Vaginal Ring; Drug: Dapivirine-Maraviroc Vaginal Ring
Sponsors: International Partnership for Microbicides, Inc.; International Partnership for Microbicides, Inc.
Recruiting - verified November 2011 - Condition: Trichomonas Vaginitis
Interventions: Drug: oral metronidazole; Drug: neo penotran forte; Drug: neo penotran forte once a day
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; Embil Pharmaceutical Co. Ltd
Recruiting - verified January 2012 - Condition: Atrophic Vaginitis
Intervention: Drug: Gynoflor
Sponsors: Medinova AG; Medinova AG
Recruiting - verified January 2011 - Conditions: Vulvovaginal Atrophy; Dyspareunia Among Puerperal Women
Intervention: Drug: Estriol 0.1% vaginal cream
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified April 2012 - Conditions: Ureteral Stent Occlusion; Exposure Laser; Ureterostomy; Functional Disturbance; Vaginal Diseases; Injury of Bladder; Excessive Repair; Calculi
Intervention:
Sponsors: Hahnemann University Hospital; Hahnemann University Hospital; Baxter Healthcare Corporation
Recruiting - verified March 2011 - Conditions: Pregnancy; Vulvovaginitis; Uterine Cervicitis; Pregnancy Outcome
Intervention: Other: Active search of lower genital tract infections
Sponsors: UPECLIN HC FM Botucatu Unesp; UPECLIN HC FM Botucatu Unesp
Not yet recruiting - verified July 2011 - Condition: Pelvic Organ Prolapse
Interventions: Procedure: Robot-assisted promontofixation; Procedure: Non-robot assisted promontofixation
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified September 2011 - Conditions: Anal Sphincter Injury; Fecal Incontinence
Intervention: Other: 3D transperineal Ultrasound
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Recruiting - verified January 2012 - Conditions: Vaginal Candidiasis; Bacterial Vaginosis; Trichomonal Vaginitis
Intervention: Drug: Metronidazole/Miconazole (Neo-Penotran® Forte, BAY86-5276)
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Condition: Rectocele
Interventions: Procedure: STARR rectocele repair; Procedure: Elevate mesh rectocele repair
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified February 2012 - Conditions: Bacterial Vaginosis; Candidiasis; Trichomoniasis
Interventions: Drug: Placebo; Drug: Neo-Penotran® Forte (active ingredient Metronidazole & Miconazole Nitrate)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Vaginal Vault Prolapse; Enterocele; Uterine Prolapse; Cystocele; Rectocele
Interventions: Device: Elevate mesh; Device: Sacrocolpopexy
Sponsors: Hospital Clinic of Barcelona; Francisco Carmona; American Medical Systems
Recruiting - verified March 2012 - Conditions: Bladder Cancer; Cervical Cancer; Colorectal Cancer; Endometrial Cancer; Gastrointestinal Complications; Long-term Effects Secondary to Cancer Therapy in Adults; Ovarian Cancer; Prostate Cancer; Radiation Toxicity; Sarcoma; Testicular Germ Cell Tumor; Vaginal Cancer
Interventions: Other: questionnaire administration; Procedure: gastrointestinal complications management/prevention; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust
Recruiting - verified March 2010 - Condition: Recurrent Vulvovaginal Candidiasis
Interventions: Biological: PEV7C1; Biological: PEV7C9; Biological: PEV7B2; Biological: PEV7B1
Sponsors: Pevion Biotech Ltd; Pevion Biotech Ltd
Recruiting - verified March 2012 - Conditions: Atrophic Vaginitis; Breast Cancer
Intervention: Drug: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified April 2012 - Condition: Vesico-vaginal Fistula
Intervention: Device: Surgisis Biodesign (Vesico-vaginal fistula plug)
Sponsors: Cook; Cook
Recruiting - verified December 2011 - Condition: Cancer
Intervention: Other: biologic sample preservation procedure
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Conditions: Uterine Fibroid; Vaginal Bleeding.
Intervention: Drug: mifepristone vaginal tablets
Sponsors: BioPro Medical Ltd; BioPro Medical Ltd
Recruiting - verified September 2010 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer
Intervention: Behavioral: online platform "STAR" (Symptom Tracking and Reporting for Patients)
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: Endometrial Cancer; Fatigue; Neurotoxicity
Interventions: Drug: carboplatin; Drug: paclitaxel; Radiation: brachytherapy; Radiation: intensity-modulated radiation therapy; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Cervical Cancer; Endometrial Cancer; Vaginal Cancer
Intervention: Procedure: CT or MRI + Blood Test
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified December 2011 - Conditions: Cervical Cancer; Endometrial Cancer; Vaginal Cancer; Vulvar Cancer; Gynecologic Cancer
Intervention: Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Condition: Bacterial Vaginosis
Interventions: Drug: Gelatin; Drug: Boric acid; Drug: Metronidazole
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified April 2012 - Condition: Bacterial Vaginosis
Interventions: Other: Probiotic lactobacilli; Other: Placebo
Sponsors: University Ghent; University Ghent; IWT, Belgium
Recruiting - verified February 2012 - Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Uterine Neoplasms; Endometrial Cancer; Vaginal Cancer; Vulvar Cancer; Cervical Cancer; Lung Cancer; Carcinoid Tumor of Lung; Sarcoma of Lung; Mesothelioma; Colorectal Cancer
Intervention:
Sponsors: Precision Therapeutics; Precision Therapeutics
Recruiting - verified June 2011 - Condition: Bacterial Vaginosis
Interventions: Other: No Intervention; Drug: Metronidazole
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Pregnant Women
Interventions: Drug: Clindamycin; Drug: Placebo; Drug: Clindamycin
Sponsors: University Hospital, Lille; University Hospital, Lille; Pfizer
Recruiting - verified January 2008 - Condition: Vaginal Cancer
Intervention: Behavioral: QOL
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified January 2012 - Conditions: Appendicitis; Cholelithiasis; Gallstones
Interventions: Procedure: Transvaginal Appendectomy; Procedure: Transvaginal Cholecystectomy
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified July 2011 - Conditions: Vaginal Atrophy; Vulvar Atrophy
Intervention: Drug: VG101
Sponsors: Bionovo; Bionovo
Not yet recruiting - verified February 2012
 |
Join Clinical Trials That Study Disorders of the Vagina |
